Paper41599232
Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells.
Cesca BA and 2 others. Pharmaceutics, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells. Papers, record 41599232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PICT 2020/00051 | Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación | PubMed | ||
| 2024 | National University of Río Cuarto | PubMed |
Source PubMed
References260
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1701343 | Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. | Cancer Res | 1990 | https://conductscience.org/library/papers/1701343 | PubMed |
| 2 | 38031182 | The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/38031182 | PubMed |
| 3 | 33855018 | Elucidating the Biomechanics of Leukocyte Transendothelial Migration by Quantitative Imaging. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33855018 | PubMed |
| 4 | 29273086 | Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. | Stem Cell Res Ther | 2017 | https://conductscience.org/library/papers/29273086 | PubMed |
| 5 | 25326491 | RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. | Cancer Res | 2014 | https://conductscience.org/library/papers/25326491 | PubMed |
| 6 | 35921473 | Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35921473 | PubMed |
| 7 | 31629410 | Tumor-associated macrophages: an accomplice in solid tumor progression. | J Biomed Sci | 2019 | https://conductscience.org/library/papers/31629410 | PubMed |
| 8 | 37190507 | Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies. | Brain Sci | 2023 | https://conductscience.org/library/papers/37190507 | PubMed |
| 9 | 38474286 | Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474286 | PubMed |
| 10 | 31649208 | Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders. | Biomol Ther (Seoul) | 2020 | https://conductscience.org/library/papers/31649208 | PubMed |
| 11 | 29422647 | Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. | Nat Commun | 2018 | https://conductscience.org/library/papers/29422647 | PubMed |
| 12 | 31728942 | Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/31728942 | PubMed |
| 13 | 37474525 | Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1. | Nat Commun | 2023 | https://conductscience.org/library/papers/37474525 | PubMed |
| 14 | 37470820 | Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks. | Appl Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/37470820 | PubMed |
| 15 | 32943658 | Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma. | Sci Rep | 2020 | https://conductscience.org/library/papers/32943658 | PubMed |
| 16 | 34209703 | Macrophage Polarization States in the Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34209703 | PubMed |
| 17 | 38852095 | Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment. | Cytotherapy | 2024 | https://conductscience.org/library/papers/38852095 | PubMed |
| 18 | 30034643 | Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities. | J Extracell Vesicles | 2018 | https://conductscience.org/library/papers/30034643 | PubMed |
| 19 | 33368262 | Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3. | J Cell Physiol | 2021 | https://conductscience.org/library/papers/33368262 | PubMed |
| 20 | 30393022 | Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2. | Life Sci | 2018 | https://conductscience.org/library/papers/30393022 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882426 | Stromal Remodeling of the Cytokine Secretome Reveals a Chemokine Core Across Breast Cancer and Glioma 3D Cell Culture Models. | Cells | 2026 | https://conductscience.org/library/papers/42882426 | PubMed |
| 42840645 | Extracellular vesicles as biomimetic platforms for photo-assisted cancer therapy: evolution from synthetic nanocarriers to engineered therapeutic systems. | Front Oncol | 2026 | https://conductscience.org/library/papers/42840645 | PubMed |
| 42797367 | Mechanism-Driven Design of Metal-Phenolic Networks: From Precision Assembly to Multidimensional Synergistic Therapy for Brain Diseases. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797367 | PubMed |
| 42338608 | Rearming mesenchymal stem cells with engineering strategies to combat cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42338608 | PubMed |
| 42192855 | New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition). | Brain Sci | 2026 | https://conductscience.org/library/papers/42192855 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599232
GET https://conductscience.org/api/papers/v1/41599232/references?page=2